John Adolf Bach, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1473 S 600 E, S Salt Lake, UT 84105 Phone: 801-487-1010 |
News Archive
genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.
Perioperative IT is seeing significant growth, particularly in Anesthesia Information Management Systems (AIMS) and analytics solutions, according to Atlanta-based Surgical Information Systems ("SIS"). In a recent survey of healthcare decision makers, 84% of those surveyed consider IT solutions as a strategic driver of success in the OR. The survey of 292 healthcare decision makers was sponsored by SIS.
The time that cancer patients nationwide spend when they travel to, wait for and receive inpatient and outpatient treatment costs an estimated $2.3 billion in the first year after diagnosis, according to a study published on Wednesday in the Journal of the National Cancer Institute, the AP/South Florida Sun-Sentinel reports.
Oligomerix, Inc. today announced the receipt of a two-year Small Business Innovation Research (SBIR) Phase II grant for $1.6M from the National Institute on Aging, National Institutes of Health (NIH), for a program to discover small molecules and antibodies targeting tau protein oligomers in the development of disease modifying therapeutics for Alzheimer's disease.
A hormone made by the body may be a potential therapeutic tool for the treatment of two anemic blood disorders beta-thalassemia and hemochromatosis. The new research was led by scientists at Weill Cornell Medical College and published in the Journal of Clinical Investigation and the journal Blood.
› Verified 4 days ago